|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Humphris JL, Johns AL, Simpson SH, Cowley
MJ, Pajic M, Chang DK, Nagrial AM, Chin VT, Chantrill LA, Pinese M,
et al Australian Pancreatic Cancer Genome Initiative: Clinical and
pathologic features of familial pancreatic cancer. Cancer.
120:3669–3675. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hidalgo M: New insights into pancreatic
cancer biology. Ann Oncol. 23(Suppl 10): x135–x138. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garrido-Laguna I and Hidalgo M: Pancreatic
cancer: From state-of-the-art treatments to promising novel
therapies. Nat Rev Clin Oncol. 12:319–334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Von Hoff DD, Ervin T, Arena FP, Chiorean
EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, et
al: Increased survival in pancreatic cancer with nab-paclitaxel
plus gemcitabine. N Engl J Med. 369:1691–1703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yassine F, Salibi E and Gali-Muhtasib H:
Overview of the formulations and analogs in the taxanes' story.
Curr Med Chem. 23:4540–4558. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mantripragada KC and Safran H: Optimizing
initial chemotherapy for metastatic pancreatic cancer. Future
Oncol. 12:1125–1133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu H, Dong Y, Gao Y, Du Z, Wang Y, Cheng
P, Chen A and Huang H: The fascinating effects of baicalein on
cancer: A review. Int J Mol Sci. 17:172016. View Article : Google Scholar
|
|
10
|
Donald G, Hertzer K and Eibl G: Baicalein
- an intriguing therapeutic phytochemical in pancreatic cancer.
Curr Drug Targets. 13:1772–1776. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu JY, Tsai KW, Li YZ, Chang YS, Lai YC,
Laio YH, Wu JD and Liu YW: Anti-bladder-tumor effect of baicalein
from Scutellaria baicalensis Georgi and its application in vivo.
Evid Based Complement Alternat Med. 2013:5797512013.PubMed/NCBI
|
|
12
|
Taniguchi H, Yoshida T, Horinaka M, Yasuda
T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T and Sakai
T: Baicalein overcomes tumor necrosis factor-related
apoptosis-inducing ligand resistance via two different
cell-specific pathways in cancer cells but not in normal cells.
Cancer Res. 68:8918–8927. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang L, Ling Y, Chen Y, Li CL, Feng F, You
QD, Lu N and Guo QL: Flavonoid baicalein suppresses adhesion,
migration and invasion of MDA-MB-231 human breast cancer cells.
Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang CZ, Zhang CF, Chen L, Anderson S, Lu
F and Yuan CS: Colon cancer chemopreventive effects of baicalein,
an active enteric microbiome metabolite from baicalin. Int J Oncol.
47:1749–1758. 2015.PubMed/NCBI
|
|
15
|
Li-Weber M: New therapeutic aspects of
flavones: The anticancer properties of Scutellaria and its main
active constituents Wogonin, Baicalein and Baicalin. Cancer Treat
Rev. 35:57–68. 2009. View Article : Google Scholar
|
|
16
|
Lu QY, Zhang L, Moro A, Chen MC, Harris
DM, Eibl G and Go VL: Detection of baicalin metabolites baicalein
and oroxylina in mouse pancreas and pancreatic xenografts.
Pancreas. 41:571–576. 2012. View Article : Google Scholar :
|
|
17
|
Takahashi H, Chen MC, Pham H, Angst E,
King JC, Park J, Brovman EY, Ishiguro H, Harris DM, Reber HA, et
al: Baicalein, a component of Scutellaria baicalensis, induces
apoptosis by Mcl-1 down-regulation in human pancreatic cancer
cells. Biochim Biophys Acta. 1813:1465–1474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Caparello C, Meijer LL, Garajova I,
Falcone A, Le Large TY, Funel N, Kazemier G, Peters GJ, Vasile E
and Giovannetti E: FOLFIRINOX and translational studies: Towards
personalized therapy in pancreatic cancer. World J Gastroenterol.
22:6987–7005. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goel G and Sun W: Novel approaches in the
management of pancreatic ductal adenocarcinoma: Potential promises
for the future. J Hematol Oncol. 8:442015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ghosn M, Ibrahim T, Assi T, El Rassy E,
Kourie HR and Kattan J: Dilemma of first line regimens in
metastatic pancreatic adenocarcinoma. World J Gastroenterol.
22:10124–10130. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mu J, Liu T, Jiang L, Wu X, Cao Y, Li M,
Dong Q, Liu Y and Xu H: The traditional Chinese medicine baicalein
potently inhibits gastric cancer cells. J Cancer. 7:453–461. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng YH, Yin LH, Grahn TH, Ye AF, Zhao YR
and Zhang QY: Anticancer effects of baicalein on hepatocellular
carcinoma cells. Phytother Res. 28:1342–1348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Seo MJ, Choi HS, Jeon HJ, Woo MS and Lee
BY: Baicalein inhibits lipid accumulation by regulating early
adipogenesis and m-TOR signaling. Food Chem Toxicol. 67:57–64.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang CZ, Calway TD, Wen XD, Smith J, Yu C,
Wang Y, Mehendale SR and Yuan CS: Hydrophobic flavonoids from
Scutellaria baicalensis induce colorectal cancer cell apoptosis
through a mitochondrial-mediated pathway. Int J Oncol.
42:1018–1026. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kosmidis C, Sapalidis K, Kotidis E,
Mixalopoulos N, Zarogoulidis P, Tsavlis D, Baka S, Man YG and
Kanellos J: Pancreatic cancer from bench to bedside: Molecular
pathways and treatment options. Ann Transl Med. 4:1652016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lemstrova R, Melichar B and
Mohelnikova-Duchonova B: Therapeutic potential of taxanes in the
treatment of metastatic pancreatic cancer. Cancer Chemother
Pharmacol. 78:1101–1111. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gong WY, Zhao ZX, Liu BJ, Lu LW and Dong
JC: Exploring the chemopreventive properties and perspectives of
baicalin and its aglycone baicalein in solid tumors. Eur J Med
Chem. 126:844–852. 2017. View Article : Google Scholar
|
|
28
|
Li J, Ma J, Wang KS, Mi C, Wang Z, Piao
LX, Xu GH, Li X, Lee JJ and Jin X: Baicalein inhibits TNF-α-induced
NF-κB activation and expression of NF-κB-regulated target gene
products. Oncol Rep. 36:2771–2776. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choi EO, Park C, Hwang HJ, Hong SH, Kim
GY, Cho EJ, Kim WJ and Choi YH: Baicalein induces apoptosis via
ROS-dependent activation of caspases in human bladder cancer 5637
cells. Int J Oncol. 49:1009–1018. 2016. View Article : Google Scholar : PubMed/NCBI
|
